Today, biomaterial-based solutions play an important role in clinical applications.
They can be implemented e.g. astissue repair scaffolds or replace elements of damaged body parts. As these biomaterials directly interact with the human body, unforseen adverse reactions can occur.
PANBioRA will develop a tool to better assess a patient-specific immune reaction to biomaterials and thus allow improved clinical outcomes.
You want to know how a mathematical platform can be used to do a screening evaluation of biomaterial biocompatibility? Then we recommend to read this article!
Have a read and get an overview on the PANBioRA Risk Radar and Rating Tools!
Join us for our PANBioRA Final Event December 1st 2021, in Strasbourg or online!